New activated macrophage-specific antigen (AcM.1) detected by a monoclonal antibody has been described. The AcM.1 antigen was only detectable on activated macrophages induced by pyran and Corynebacterium parvum but not on resident or thioglycollate medium (TGC), proteose-peptone, and mineral oil-elicited macrophages, and not on blood monocytes and neutrophils. Activated macrophages induced by pyran and C. parvum, as expected, exhibited tumor cytotoxicity, whereas TGC-elicited macrophages did not show any cytotoxicity. Moreover, pretreatment of pyran-activated peritoneal exudate cells with AcM.1 antibody plus complement abolished approximately 80% cytotoxicity. Thus, this AcM.1 antigen detected by a monoclonal antibody is the first unique marker of activated tumoricidal macrophages and should provide a useful probe for investigating the mechanisms of activation or differentiation of macrophages.
No takes yet. Share an insight, caveat, or question.
Taniyama et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: